Aspartylglucosaminuria is a rare lysosomal storage disorder that occurs as a result of a deficiency of the aspartylglucosaminidase enzyme. Because the disease is commonly referred to as the Finnish disease heritage, it is underdiagnosed outside of Finland. To date, only three Turkish patients are described in the literature. Here we describe the clinical and brain magnetic resonance imaging findings in two Turkish cousins with aspartylglucosaminuria, which can raise the suspicion of this rare disease in clinical practice.
Introduction
Aspartylglucosaminuria (AGU) is an autosomal recessive metabolic disorder characterized by the deficiency of the lysosomal enzyme (aspartylglucosaminidase (AGA)) which catalyzes the degradation of glycoprotein. 1 AGU usually presents with progressive intellectual disability within the first years of life with delayed speech development, facial dysmorphism, behavioral problems, seizure and hepatosplenomegaly. 2 The clinical features of AGU were first described in 1972 by Autio in 57 Finnish patients and so far, except for a few sporadic cases, AGU has been mostly determined among Finnish families. 3 There are few reports regarding magnetic resonance imaging (MRI) findings in children with AGU. 4, 5 In a recent review of 20 patients with AGU, the authors reported the most typical abnormalities at MRI. 6 These findings included delayed myelination, poor differentiation of cortical gray versus white matter, decreased T2 signal intensity in the thalami, especially in the pulvinar nuclei, and increased T2 signal intensity in the periventricular white matter and cortical atrophy. Furthermore, the study also disclosed various unspecific findings including dilated perivascular spaces, arachnoid cysts, pineal cysts and mildly dilated cavum veli interpositi.
To date, only three Turkish patients have been reported in the literature. We report here the clinical and brain MRI findings of two male cousins who presented with developmental delay and atypical facial features.
Clinical course of cases
Case 1, the second child of a consanguineous Turkish family, a 12-year-old boy, was seen in our department for the evaluation of moderate psychomotor retardation and behavioral abnormalities.
There was a family history of mental retardation in one male cousin, maternal uncle and maternal aunt (as indicated in the family tree in Figure 1 ).
According to his parents, the child's developmental milestones have been abnormal since infancy. He began to sit up at 12 months, walk at two years, and he started talking when he was six years old. However, he could not establish sentences. His medical history was also positive for recurrent upper respiratory tract infections and his surgical history was significant for two inguinal hernia operations. There was no history of seizures or visual/hearing insufficiency. Physical examination demonstrated a height and weight of 137 cm (third percentile) and 40 kg (25-50th percentile), respectively, and a head circumference of 53.5 cm (25-50th percentile). He showed coarse facial features, enlarged head, broad nose, wide nasal bridge and thickened lips.
Neurological examination showed normal tone, power and deep tendon reflexes with bilateral flexor plantar response. The boy showed mental retardation and mild motor delay. He could not express himself but could say simple terms such as mama and papa. Otherwise, the physical examination was unremarkable; in particular, no hepatosplenomegaly and corneal cloud were found.
His maternal cousin (case 2) was admitted to our department at the age of eight because of speech delay, progressive hyperactivity and behavioral problems from two years of age. He also had a past surgical history of myringotomy due to recurrent ear infections.
When his parents were questioned about the patient's medical history, they revealed that he was able to walk at two years six months, his first meaningful word was spoken at the age of two and he began to use sentences when he was six years old.
On physical examination, the patient's weight and head circumference were both at approximately the 50-75th percentile. His height was lower than the third percentile for his age. He appeared to have mildly dysmorphic craniofacial features, including hypertelorism, a short and board nose with round nares and thick lips. The boy presented with anxious and restless behavior. Neurological examination showed normal tone, power and deep tendon reflexes with bilateral flexor plantar response.
Investigations and biochemical tests
Basic laboratory results were normal. Intensive metabolic investigations (including lactate, ammonia, amino acids, organic acids and very-long-chain fatty acids) were all normal. Urinary oligosaccharide analysis detected an abnormal excretion of aspartylglucosamine in both patients. In fibroblasts of both patients, aspartylglucosaminidase activity was markedly decreased (0.8 and 0.53 umol/L/h) compared to the normal reference range (10-60 umol/L/h). All other lysosomal enzymes measured showed normal activity. The diagnosis of AGU was confirmed. AGA mutation analysis were suggested to both parents, but they refused.
Brain MRI of both patients were performed with a 1.5T Magnetom Vision system (Siemens, Erlangen, Germany) including turbo spin-echo T2-weighted axial (repetition time/echo time (TR/TE) 6000/125 ms, slice thickness 5 mm, gap 1 mm) and coronal (TR/TE 4200/97 ms) images, and axial fluid-attenuated inversion recovery (fluid attenuation inversion recovery (FLAIR); TR/TE/inversion time 9000/119/31 ms, slice thickness 5 mm, gap 1 mm).
Brain MRI of case 1 showed J-shaped sella turcica, type 1 Chiari malformation, with the cerebellar tonsils 9 mm below the level of the foramen magnum, slightly enlarged lateral ventricles, thinning of the corpus callosum, increased T2 signal intensity in the periventricular white matter, decreased T2 signal intensity in the pulvinar nuclei, poor differentiation between grey and white matter and enlarged perivascular spaces in the bilateral parietal region (Figure 2 ).
Brain MRI of case 2 showed J-shaped sella turcica, poor differentiation between grey and white matter, increased T2 signal intensity in the periventricular white matter, decreased T2 signal intensity in the pulvinar nuclei, mild widening of the lateral ventricles with thinning of the corpus callosum, enlarged perivascular spaces in the bilateral parietal region and vermis atrophy or retrocerebellar cyst (Figure 3 ).
Discussion
AGU is relatively common in Finland and it has been reported as the third most common cause of intellectual disability after trisomy 21 and fragile X syndrome. 7 However, the number of patients outside of Finland feature far less in the literature. Here we report the clinical and brain MRI findings of two patients. To the best of our knowledge, these two patients represent the fourth and fifth Turkish cases to be reported in the literature. 8 AGU is an inherited metabolic disorder characterized by the deficiency in the degradation of oligosaccharides and leading to an abnormal accumulation of oligosaccharides in various tissues. The hallmark of this lysosomal storage of oligosaccharides is progressive intellectual decline, markedly behavioral problems, hyperactivity, recurrent infections, epilepsy and facial dysmorphism, including coarse facies, macrocephalus and gingival hyperplasia.
In our patients, the first sign that attracted our attention was the coarse facial features. The clinical course of AGU, as mentioned above, is similar to mucopolysaccharidosis. 9 In addition, imaging studies of the patients with mucopolysaccharidosis have shown J-shaped sella turcica -small perivascular spaces in various brain regions as were observed in our patients. Therefore, we firstly examined mucopolysaccharidosis as a possible diagnosis. However, the patients' skeletal surveys were not suggestive of the characteristic dysostosis complex, laboratory examination revealed normal urine glycosaminoglycans and enzyme analysis for all mucopolysaccharidosis types showed normal activity.
Brain MRI of our patients showed J-shaped sella turcica, type 1 Chiari malformation, with the cerebellar tonsils 9 mm below the level of the foramen magnum, slight widening of the lateral ventricles, thinning of the corpus callosum, decreased T2 signal intensity in the pulvinar nuclei, increased T2 signal intensity in the periventricular white matter, poor differentiation between grey and white matter and enlarged perivascular spaces in the bilateral parietal region. These findings are similar to those previously reported. [4] [5] [6] In addition, we found J-shaped sella turcica and Chiari 1 malformation.
Bilateral thalamic signal intensity changes are accepted as an indication of lysosomal disorders, but among these AGU is the only one with marked T2 hypointensity in the pulvinar nuclei. [4] [5] [6] In conclusion, although AGU is a very rare disease outside of Finland, sporadic cases exist worldwide. The diagnosis of AGU can be difficult to make; the clinical symptoms may be subtle and signs may be variable, thus delaying the diagnosis. Therefore, when there is a question of unexplained intellectual disability, typical brain MRI findings can raise a suspicion of AGU. We recommend that also outside of Finland, laboratory screening for AGU should be carried out in all patients with unexplained psychomotor retardation and brain MRI findings found in AGU.
